Fazzari v. New Hanover Reg'l Med. Ctr.

CourtCourt of Appeals of North Carolina
DecidedJune 1, 2021
Docket20-473
StatusPublished

This text of Fazzari v. New Hanover Reg'l Med. Ctr. (Fazzari v. New Hanover Reg'l Med. Ctr.) is published on Counsel Stack Legal Research, covering Court of Appeals of North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Fazzari v. New Hanover Reg'l Med. Ctr., (N.C. Ct. App. 2021).

Opinion

IN THE COURT OF APPEALS OF NORTH CAROLINA

2021-NCCOA-242

No. COA20-473

Filed 1 June 2021

New Hanover County, No. 17 CRS 3609

ESTATE OF ANTHONY FAZZARI by RUTH FAZZARI, Executrix; and RUTH FAZZARI, Plaintiffs,

v.

NEW HANOVER REGIONAL MEDICAL CENTER; WILMINGTON HEALTH, PLLC; SEJAL S. PATEL, M.D. and JOSHUA D. DOBSTAFF, M.D., Defendants.

Appeal by plaintiffs from orders entered 7 January 2020 and 13 January 2020

by Judge Phyllis M. Gorham in New Hanover County Superior Court. Heard in the

Court of Appeals 28 April 2021.

Chleborowicz Law Firm, PLLC, by Christopher A. Chleborowicz and Elijah A. T. Huston, for plaintiffs-appellants.

Harris, Creech, Ward & Blackerby, P.A., by R. Brittain Blackerby and Terra N. Johnson, for defendant-appellee New Hanover Regional Medical Center.

Walker, Allen, Grice, Ammons, Foy & Klick, LLC, by Jerry A. Allen, Jr., and Louis F. Foy, III, for defendants-appellees Wilmington Health, PLLC, Sejal S. Patel, M.D., and Joshua D. Dobstaff, M.D.

ARROWOOD, Judge.

¶1 The Estate of Anthony Fazzari by Ruth Fazzari, Executrix, and Ruth Fazzari FAZZARI V. NEW HANOVER REGIONAL MEDICAL CENTER ET AL.

Opinion of the Court

(collectively, “plaintiffs”) appeal from the trial court’s orders granting all defendants’1

(1) motions to dismiss; (2) motions to exclude plaintiffs’ sole testifying and standard-

of-care expert witness; and (3) summary judgment motions. For the following

reasons, we affirm the trial court’s order entered 7 January 2020 granting

defendants’ motions to dismiss pursuant to Rule 9(j) of the North Carolina Rules of

Civil Procedure.

I. Background

¶2 At all times relevant, Anthony Fazzari (“decedent”) was a 77-year-old man with

a history of multiple myeloma and myelodysplastic syndrome. Decedent had been

periodically admitted to defendant New Hanover Regional Medical Center

(“NHRMC”) for neutropenic fever and other complications related to multiple

myeloma and myelodysplastic syndrome.

¶3 On 12 April 2016, NHRMC admitted decedent to the care of defendant Sejal S.

Patel, M.D. (“Dr. Patel”), who noted that decedent presented signs of neutropenic

fever and had the condition of “pancytopenia: chronic”—too few red blood cells, white

blood cells, and platelets. Dr. Patel prescribed decedent 5,000 units of Heparin2 every

1 We will refer to all named defendants collectively unless otherwise noted. 2 Heparin may reduce one’s platelet count. FAZZARI V. NEW HANOVER REGIONAL MEDICAL CENTER ET AL.

eight hours as a deep vein thrombosis (“DVT”) prophylactic.3 Defendant Joshua D.

Dobstaff, M.D. (“Dr. Dobstaff”), another provider for decedent at the time, was

allegedly aware of decedent’s depressed platelet count but did not take any action to

mitigate the issue. At all times relevant, Drs. Dobstaff and Patel were employed by

defendant Wilmington Health, PLLC, and practicing as hospitalists when they

provided inpatient care to decedent at NHRMC.

¶4 On the evening of his admission, blood testing indicated that decedent’s

platelet count was 24 K/uL, far below NHRMC’s target level of 50 K/uL. Given

decedent’s low platelet count, a secure electronic message was sent to David Schultz,

M.D. (“Dr. Schultz”), regarding “critical lab value – Platelets 24” and for “review

case.”4 Notwithstanding the above, decedent was administered the previously

prescribed dose of Heparin later that night. Thereafter, at 5:44 a.m. on 13 April 2016,

decedent’s platelet count had dropped from 24 K/uL to 18 K/uL. Notwithstanding

this decrease, the orders for Heparin were not discontinued. Plaintiffs allege that

after reviewing the lab results reflecting the decrease in decedent’s platelet count,

neither Dr. Dobstaff nor Dr. Patel changed any orders (including the Heparin

3 Plaintiffs allege that at the time of decedent’s admission, his platelet count was “depressed

indicating that Heparin as a DVT prophylaxis was an inappropriate course of treatment, particularly in light of pending chemotherapy which would further depress platelet counts.” 4 Dr. Schultz is not a defendant in this case. Also, it is unclear whether there was any

response to this secure electronic message. FAZZARI V. NEW HANOVER REGIONAL MEDICAL CENTER ET AL.

prescription) and failed to take any other action to restore decedent’s platelet count

to target level. However, during the afternoon of 13 April 2016, a nurse refrained

from administering the scheduled dose of Heparin noting in decedent’s medical record

that his platelet count was 18 K/uL.

¶5 At 3:42 a.m. on 14 April 2016, decedent’s blood was again collected, and his

platelet count was determined to be 20 K/uL. Shortly thereafter, decedent

complained of a headache and requested medication. In light of these events, a

NHRMC care provider sent another secured message to Dr. Schultz stating that

decedent appeared confused, impulsive, disoriented, and was exhibiting slurred

speech. It is unclear whether Dr. Schultz or any other hospitalists responded to or

received these messages; plaintiffs allege that NHRMC did not have the correct

information on file for these secure electronic messages which prevented the listed

physician in the system from receiving the messages as he or she was not on call to

receive or respond to the communications.

¶6 Later, a physician’s assistant was notified about decedent’s deteriorating

condition. The Heparin order was discontinued approximately two hours later,

around noon on 14 April 2016, and platelet therapy was initiated. After the initiation

of platelet therapy, decedent began showing signs of stroke with a diagnosis of Acute

Brain Hemorrhage or Intracerebral Hemorrhage (“ICH”). A computerized

tomography scan was ordered, and the imaging confirmed that decedent was FAZZARI V. NEW HANOVER REGIONAL MEDICAL CENTER ET AL.

suffering from an ICH. While decedent’s platelet count had improved from the

platelet therapy and blood transfusions, decedent was not an operative candidate for

the ICH pressure. Decedent was then transferred to the Intensive Care Unit (“ICU”)

where he was treated until 20 April 2016, when decedent eventually succumbed to

the ICH.

¶7 On 21 September 2017, plaintiffs filed a complaint against all defendants

asserting claims for (1) professional negligence/wrongful death, (2) negligent

infliction of emotional distress, and (3) loss of consortium. Pursuant to Rule 9(j) of

the North Carolina Rules of Civil Procedure, plaintiffs certified that all of the medical

records pertaining to defendants’ negligence had been reviewed by a person who was

reasonably expected to qualify under Rule 702 of the North Carolina Rules of

Evidence.

¶8 On 30 May 2018, plaintiffs served responses to NHRMC’s interrogatories.

Plaintiffs’ responses identified Arnold Rubin, M.D. (“Dr. Rubin”), as plaintiffs’ Rule

9(j) expert. On 2 July 2019, plaintiffs served their designation of experts; plaintiffs’

designation of experts likewise identified Dr. Rubin as plaintiffs’ sole Rule 9(j) expert.

¶9 Defendants deposed Dr. Rubin on 5 November 2019. Following Dr. Rubin’s

deposition, defendants Wilmington Health, PLLC, Dr. Patel, and Dr. Dobstaff filed a

motion to exclude Dr. Rubin from testifying as a standard-of-care expert pursuant to

Rule 9(j) of the North Carolina Rules of Civil Procedure, Rule 702 of the North FAZZARI V. NEW HANOVER REGIONAL MEDICAL CENTER ET AL.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Weatherford v. Glassman
500 S.E.2d 466 (Court of Appeals of North Carolina, 1998)
Smith v. Whitmer
582 S.E.2d 669 (Court of Appeals of North Carolina, 2003)
Thigpen v. Ngo
558 S.E.2d 162 (Supreme Court of North Carolina, 2002)
Ford v. McCain
666 S.E.2d 153 (Court of Appeals of North Carolina, 2008)
Barham v. Hawk
600 S.E.2d 1 (Court of Appeals of North Carolina, 2004)
Fairfield v. WakeMed
821 S.E.2d 277 (Court of Appeals of North Carolina, 2018)
Estate of Wooden ex rel. Jones v. Hillcrest Convalescent Center, Inc.
731 S.E.2d 500 (Court of Appeals of North Carolina, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Fazzari v. New Hanover Reg'l Med. Ctr., Counsel Stack Legal Research, https://law.counselstack.com/opinion/fazzari-v-new-hanover-regl-med-ctr-ncctapp-2021.